SGS is expanding its Clinical Pharmacology Unit in Antwerp, Belgium with a Viral Challenge Testing facility that will include a 12-bed, biosafety level 2-Q compliant, quarantine facility, allowing the company to conduct highly specialized clinical trials.   The quarantine facility incorporates a negative pressure system, which includes individual compartments for infected volunteers, and a dedicated lab equipped with a flow cabinet, acid cabinet, workspace and workflows to handle specific (viral...